Generac's Norman P. Taffe sells 100 shares at $190

The common-stock acquisition and sale were reported under a Rule 10b5-1 plan adopted March 6, 2026.

Available on EDGAR 11/10/2026 - 04:04 PM EST Accepted by SEC EDGAR 11/10/2026 - 04:03 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Generac Holdings Inc. President Generac Home Norman P. Taffe exercised options to acquire 100 common shares at an exercise price of $119.54 per share and sold 100 common shares at $190 per share on November 9, 2026. His reported option position after the transaction covered 1,770 shares.

The common-stock acquisition and sale were reported under a Rule 10b5-1 plan adopted March 6, 2026. The options have a graded vesting schedule, with exercisability varying by tranche.

Insider Trade Summary 10b5-1

Exercise and Sale: 100 shares ($7K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Taffe Norman P

Role President Generac Home

Sold 100 shs ($19K)

Approx. gross sale proceeds $19K

Approx. exercise cost $12K

Approx. pre-tax spread $7K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F2	100	$0.00	$0.00
Exercise	Common Stock F1	100	$119.54	$12K
Sale	Common Stock F1	100	$190.00	$19K

Holdings After Transaction: Stock Option (Right to Buy) — 1,770 options (Direct); Common Stock — 10,676 shares (Direct)

Footnotes (2)

1. F1. Adoption date of referenced 10b5-1(c) plan is: 03-06-2026
2. F2. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.

Key Figures

Common shares acquired through option exercise: 100 shares Exercise price: $119.54 per share Common shares sold: 100 shares +2 more

5 metrics

Common shares acquired through option exercise 100 shares November 9, 2026

Exercise price $119.54 per share Options exercised November 9, 2026

Common shares sold 100 shares November 9, 2026

Sale price $190 per share Sale on November 9, 2026

Shares covered by reported option position after transaction 1,770 shares Following the November 9, 2026 transaction

Key Terms

Rule 10b5-1 plan, graded vesting schedule, exercise price

3 terms

Rule 10b5-1 plan regulatory

"plan adopted March 6, 2026"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

graded vesting schedule financial

"Grant has a graded vesting schedule"

exercise price financial

"exercise price of $119.54 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GNRC shares did Norman P. Taffe sell, and at what price?

Norman P. Taffe, President Generac Home, reported selling 100 common shares at $190 per share on November 9, 2026. The sale was reported under a Rule 10b5-1 plan adopted March 6, 2026.

How many GNRC shares did Norman P. Taffe acquire through option exercise?

He exercised options to acquire 100 common shares at an exercise price of $119.54 per share on November 9, 2026. His reported option position after the transaction covered 1,770 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taffe Norman P

(Last) (First) (Middle)

S45 W29290 HWY.59

C/O GENERAC HOLDINGS INC.

(Street)

WAUKESHA WISCONSIN 53189

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENERAC HOLDINGS INC. [ GNRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President Generac Home

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/09/2026		M(1)		100	A	$119.54	10,776	D
Common Stock	11/09/2026		S(1)		100	D	$190	10,676	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$119.54	11/09/2026		M			100	(2)	03/01/2033	Common Stock	100	$0	1,770	D

Explanation of Responses:

1. Adoption date of referenced 10b5-1(c) plan is: 03-06-2026

2. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.

	/s/ Raj Kanuru, Attorney in Fact	11/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)